Evidence map›Paper›PMID 10751369›Full record

ArticleThe American journal of pathology2000

Biomaterial-induced sarcoma: A novel model to study preneoplastic change.

C J Kirkpatrick, A Alves, H Köhler, J Kriegsmann, F Bittinger, M Otto, D F Williams, R Eloy

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 124 citations in OpenAlex.

  1. Review
  2. Orthopaedic Implant-Associated Rhabdomyosarcoma.The Journal of the American Academy of Orthopaedic Surgeons · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. An Update on Implant-Associated Malignancies and Their Biocompatibility.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Article
  9. Resorbable MgMaterials (Basel, Switzerland) · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Polypropylene mesh: evidence for lack of carcinogenicity.International urogynecology journal · 2014
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

C J KirkpatrickInstitute of Pathology, Johannes Gutenberg University, Mainz, Germany. kirkpatrick@pathologie.klinik.uni-mainz.de
A Alves
H Köhler
J Kriegsmann
F Bittinger
M Otto
D F Williams
R Eloy
Johannes Gutenberg University Mainz · DEUniversity of Liverpool · GBNAMSA (France) · FRZimmer Biomet (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the study of carcinogenesis most interest has focused on carcinomas, as they represent the majority of human cancers. The recognition of the adenoma-carcinoma sequence both in humans and in animal experimental models has given the field of basic oncology the opportunity to elucidate individual mechanisms in the multistep development of carcinoma. The relative scarcity of human sarcomas coupled with the lack of adequate animal models has hampered understanding of the molecular genetic steps involved. We present an experimental model in the rat in which a high incidence of malignant mesenchymal tumors arise around a subcutaneously implanted biomaterial. Nine commercially available biomaterials were implanted in a total of 490 rats of the Fischer strain for 2 years. On average, macroscopic tumors were found in 25.8% of implantation sites over a period from 26 to 110 weeks after implantation. The most frequent tumors were malignant fibrous histiocytomas and pleomorphic sarcomas, although fibrosarcomas, leiomyosarcomas, and angiosarcomas readily developed, the latter especially around polyurethane implants. Of particular interest are the results of a detailed histological study of the capsules around the implanted biomaterials without tumors. Here a spectrum of change from focal proliferative lesions through preneoplastic proliferation to incipient sarcoma could be observed. A parallel immunohistochemical study of peri-implant capsules showed that proliferating cell nuclear antigen was of particular help in identifying these atypical proliferative lesions. To our knowledge this is the first description of a sarcoma model in which preneoplastic lesions can be readily identified and also reproducibly induced. This model provides the molecular biologist with defined stages in the development of mesenchymal malignancy, with which the multistage tumorigenesis hypothesis can be tested, analogous to the well-known adenoma-carcinoma sequence.

Indexed as

Biocompatible MaterialsAnimalsDisease Models, AnimalDrug ImplantsHistiocytoma, Benign FibrousImmunohistochemistryIncidencePrecancerous ConditionsRatsRats, Inbred F344Sarcoma, ExperimentalBiocompatible MaterialsDrug Implants

Identifiers

PMID10751369
PMCPMC1876896
OpenAlexW138934520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.